Pentwater Capital Management’s Bausch Health BHC Stock Holding History

Pentwater Capital Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-45,000	Closed	-$779K	–	104
2017 Q2	$779K	Sell	45,000 -45,000	-50%	-$539K	0.01%	99
2017 Q1	$993K	Sell	90,000 -324,000	-78%	-$4.46M	0.01%	87
2016 Q4	$6.01M	Buy	414,000 +194,000	+88%	+$3.56M	0.08%	76
2016 Q3	$5.4M	Sell	220,000 -230,000	-51%	-$5.95M	0.05%	85
2016 Q2	$9.06M	Sell	450,000 -670,000	-60%	-$19M	0.12%	60
2016 Q1	$29.5M	Buy	1,120,000 +135,000	+14%	+$9.98M	0.22%	42
2015 Q4	$100M	Buy	+985,000	New	+$111M	0.69%	26
2015 Q3	–	Sell	-30,100	Closed	-$6.69M	–	137
2015 Q2	$6.69M	Sell	30,100 -289,900	-91%	-$64.3M	0.04%	113
2015 Q1	$63.6M	Sell	320,000 -600,000	-65%	-$106M	0.48%	37
2014 Q4	$132M	Buy	920,000 +40,000	+5%	+$5.38M	0.94%	28
2014 Q3	$115M	Buy	880,000 +500,000	+132%	+$59.6M	1.11%	25
2014 Q2	$47.9M	Buy	+380,000	New	+$48.5M	0.51%	36

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pentwater Capital Management's BHC Position: Q1 2018 in Review

Pentwater Capital Management sold out of Bausch Health (BHC) in Q1 2018, closing a stake of 761,700 shares — an estimated $15.8M sold.

Pentwater Capital Management first reported a position in BHC in Q2 2014 and held it in 12 quarters. The position peaked at $205M in Q3 2014. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2018.

Pentwater Capital Management reported no remaining Bausch Health position as of Q1 2018 after selling out during the quarter.
Pentwater Capital Management sold 761,700 Bausch Health shares in Q1 2018, an estimated $15.8M.
Pentwater Capital Management first reported a position in Bausch Health in Q2 2014 and held it in 12 quarters.
Pentwater Capital Management's Bausch Health position peaked at $205M in Q3 2014.
327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2018.

Based on Pentwater Capital Management's 13F filing for Q1 2018, filed 15 May 2018.